References
- Stark AM, Tscheslog H, Buhl R, et al. Surgical treatment for brain metastases: Prognostic factors and survival in 177 patients. Neurosurg Rev 2005; 28: 115–119
- Weil RJ, Palmieri DC, Bronder JL, et al. Breast cancer metastasisto the central nervous system. Am J Pathol 2005; 167: 913–920
- Debies MT, Welch DR. Genetic basis of human breast cancer metastasis. J Mamm Gland Biol Neopl 2002; 6: 441–451
- Welch DR, Steeg PS, Rinker-Schaeffer CW. Molecular biology of breast cancer metastasis — genetic regulation of human breast carcinoma metastasis. Breast Cancer Res 2000; 2: 408–416
- Stark AM, Tongers K, Maass N, et al. Reduced metastasis-suppressor gene mRNA-expression in breast cancer brain metas-tases. J Cancer Res Clin Oncol 2005; 131: 179–183
- Bieche I, Girault I, Sabourin JC, et al. Prognostic value of maspinmRNA expression in ER alpha-positive postmenopausal breast carcinomas. Br J Cancer 2003; 88: 863–870
- Zou Z, Anisowicz A, Hendrix MJ, et al. Maspin, a serpin with tumor-suppressing activity in human mammary epithelial cells. Science 1994; 263: 526–529
- Latha K, Zhang W, Cella N, et al. Maspin mediates increased tumor cell apoptosis upon induction of the mitochondrial permeability transition. Mol Cell Biol 2005; 25: 1737–1748
- Li Z, Shi HY, Zhang M. Targeted expression of maspin in tumorvasculatures induces endothelial cell apoptosis. Oncogene 2005; 24: 2008–2019
- Schaefer JS, Zhang M. Role of maspin in tumor metastasis and angiogenesis. Curr Mol Med 2003; 3: 653–658
- Seftor RE, Seftor EA, Sheng S, et al. Maspin suppresses the invasive phenotype of human breast carcinoma. Cancer Res 1998; 58: 5681–5685
- Odero-Marah VA, Khalkhali-Ellis Z, Chunthapong J, et al. Maspin regulates different signaling pathways for motility and adhesion in aggressive breast cancer cells. Cancer Biol Ther 2003; 2: 398–403
- Maass N, Hojo T, Rosel F, et al. Down regulation of the tumor suppressor gene maspin in breast carcinoma is associated with a higher risk of distant metastasis. Clin Biochem 2001; 34: 303–307
- Schaefer JS, Zhang M. Targeting maspin in endothelial cells to induce cell apoptosis. Expert Opin Ther Targets 2006; 10: 401–408
- Umekita Y, Yoshida H. Expression of maspin is up-regulated during the progression of mammary ductal carcinoma. Histopathology 2003; 42: 541–545
- Mohsin SK, Zhang M, Clark GM, et al. Maspin expression in invasive breast cancer: Association with other prognostic factors. J Pathol 2003; 199: 432–435
- Remmele W, Stegner HE. [Recommendation for uniform defini-tion of an immunoreactive score (IRS) for immunohistochemical estrogen receptor detection (ER-ICA) in breast cancer tissue]. Pathologe 1987; 8: 138–140
- Liu Z, Shi HY, Nawaz Z, et al. Tamoxifen induces the expression of maspin through estrogen receptor-alpha. Cancer Lett 2004; 209: 55–65
- van Rijswijk RE, van Oostenbrugge RJ, Twijnstra A. A case of brain metastases from male breast cancer responding to tamoxifen. Eur J Cancer 1997; 33: 2282–2283
- Stemmler Hi, Kahlert S, Siekiera W, et al. Characteristics of patients with brain metastases receiving trastuzumab for HER2 overexpressing metastatic breast cancer. Breast 2006; 15: 219–225
- Pemberton PA, Tipton AR, Pavloff N, et al. Maspin is an intra-cellular serpin that partitions into secretory vesicles and is present at the cell surface. J Histochem Cytochem 1997; 45: 1697–1706
- Maas N, Biallek M, Rosel F, et al. Biochem Biophys Res Commun 2002; 297: 125–128